Tags

Type your tag names separated by a space and hit enter

MEDICATION ASSISTED TREATMENT (MAT) FOR OPIOID USE DISORDERS (OUDS): OPINION AND EXPERIENCES OF SUBSTANCE USE PROFESSIONALS (SUPS) IN NIGERIA.
West Afr J Med. 2024 Nov 10; 41(11 Suppl 1):S51.WA

Abstract

Background

Rates of drug use in Nigeria is one of the highest globally, with the use of opioids associated with increased morbidity and mortality more so with injecting drug use (IDU). MAT) can reduce the harmful effects of opioid use but usage in the country is low despite a country-specific guideline in place. A notable barrier to MAT uptake is professionals' knowledge and attitudes. This study aimed to evidence the opinions of Substance use professionals (SUPs) in Nigeria regarding MAT.

Objective

To ascertain the opinions of SUPs in Nigeria regarding MAT prescriptions for opioid dependence.

Methods

An online Google form was developed by the researchers to assess knowledge and attitudes towards MAT. This form was circulated among SUPs across the six geopolitical zones and the capital territory in Nigeria.

Results

Three hundred and twenty-nine professionals completed the questionnaire. Most were medical doctors (53.8%) and worked in the public sector (89%). Average work experience was 11 years and respondents estimated that nearly 1 in 10 OUD patients they cared for were IDUs. A majority (85.7%) endorsed the need for MAT in Nigeria, though had no previous experience (65.3%), training (74.2%) or knowledge of existing guidelines (68.7%). Over half (55%) endorsed a preference for the availability of buprenorphine and methadone. Most endorsed positive attitudes towards MAT prescriptions.

Conclusion

Substance use professionals endorsed positive attitudes towards MAT for OUDs and its rollout in Nigeria. Awareness of published guidelines and training are unmet needs arising from this study. Keywords: Medical assisted treatment (MAT), opioid use disorders, opinion and experiences.

Authors+Show Affiliations

Nigeria International Technology Transfer Centre (Nigeria ITTC). Email: utehb@yahoo.com. Federal Neuropsychiatric Hospital, Benin-City, Nigeria.Nigeria International Technology Transfer Centre (Nigeria ITTC). Email: utehb@yahoo.com. Federal Neuropsychiatric Hospital, Benin-City, Nigeria.Nigeria International Technology Transfer Centre (Nigeria ITTC). Email: utehb@yahoo.com.Federal Neuropsychiatric Hospital Maiduguri, Nigeria.Department of Psychiatry, University of Jos, Plateau State, Nigeria. Netwealth Centre for Addiction Management and Psychological Medicine, Jos, Plateau State, Nigeria.Federal Neuropsychiatric Hospital Kaduna, Nigeria.Federal Neuropsychiatric Hospital, Yaba, Lagos, Nigeria.Federal Neuropsychiatric Hospital Enugu, Nigeria.

Pub Type(s)

Journal Article
English Abstract

Language

eng

PubMed ID

39544093

Citation

Uteh, B E A., et al. "MEDICATION ASSISTED TREATMENT (MAT) for OPIOID USE DISORDERS (OUDS): OPINION and EXPERIENCES of SUBSTANCE USE PROFESSIONALS (SUPS) in NIGERIA." West African Journal of Medicine, vol. 41, no. 11 Suppl 1, 2024, pp. S51.
Uteh BEA, Ariyo JO, James BO, et al. MEDICATION ASSISTED TREATMENT (MAT) FOR OPIOID USE DISORDERS (OUDS): OPINION AND EXPERIENCES OF SUBSTANCE USE PROFESSIONALS (SUPS) IN NIGERIA. West Afr J Med. 2024;41(11 Suppl 1):S51.
Uteh, B. E. A., Ariyo, J. O., James, B. O., Mshelia, I. A., Okonoda, K. M., Salihu, H. B., Esangbedo, A. E., & Orovwigho, A. O. (2024). MEDICATION ASSISTED TREATMENT (MAT) FOR OPIOID USE DISORDERS (OUDS): OPINION AND EXPERIENCES OF SUBSTANCE USE PROFESSIONALS (SUPS) IN NIGERIA. West African Journal of Medicine, 41(11 Suppl 1), S51.
Uteh BEA, et al. MEDICATION ASSISTED TREATMENT (MAT) for OPIOID USE DISORDERS (OUDS): OPINION and EXPERIENCES of SUBSTANCE USE PROFESSIONALS (SUPS) in NIGERIA. West Afr J Med. 2024 Nov 10;41(11 Suppl 1):S51. PubMed PMID: 39544093.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - MEDICATION ASSISTED TREATMENT (MAT) FOR OPIOID USE DISORDERS (OUDS): OPINION AND EXPERIENCES OF SUBSTANCE USE PROFESSIONALS (SUPS) IN NIGERIA. AU - Uteh,B E A, AU - Ariyo,J O, AU - James,B O, AU - Mshelia,I A, AU - Okonoda,K M, AU - Salihu,H B, AU - Esangbedo,A E, AU - Orovwigho,A O, PY - 2024/11/16/medline PY - 2024/11/15/pubmed PY - 2024/11/15/entrez KW - Medical assisted treatment (MAT) KW - Opinion and experiences KW - Opioid use disorders SP - S51 EP - S51 JF - West African journal of medicine JO - West Afr J Med VL - 41 IS - 11 Suppl 1 N2 - Background: Rates of drug use in Nigeria is one of the highest globally, with the use of opioids associated with increased morbidity and mortality more so with injecting drug use (IDU). MAT) can reduce the harmful effects of opioid use but usage in the country is low despite a country-specific guideline in place. A notable barrier to MAT uptake is professionals' knowledge and attitudes. This study aimed to evidence the opinions of Substance use professionals (SUPs) in Nigeria regarding MAT. Objective: To ascertain the opinions of SUPs in Nigeria regarding MAT prescriptions for opioid dependence. Methods: An online Google form was developed by the researchers to assess knowledge and attitudes towards MAT. This form was circulated among SUPs across the six geopolitical zones and the capital territory in Nigeria. Results: Three hundred and twenty-nine professionals completed the questionnaire. Most were medical doctors (53.8%) and worked in the public sector (89%). Average work experience was 11 years and respondents estimated that nearly 1 in 10 OUD patients they cared for were IDUs. A majority (85.7%) endorsed the need for MAT in Nigeria, though had no previous experience (65.3%), training (74.2%) or knowledge of existing guidelines (68.7%). Over half (55%) endorsed a preference for the availability of buprenorphine and methadone. Most endorsed positive attitudes towards MAT prescriptions. Conclusion: Substance use professionals endorsed positive attitudes towards MAT for OUDs and its rollout in Nigeria. Awareness of published guidelines and training are unmet needs arising from this study. Keywords: Medical assisted treatment (MAT), opioid use disorders, opinion and experiences. SN - 0189-160X UR - https://www.unboundmedicine.com/medline/citation/39544093/ DB - PRIME DP - Unbound Medicine ER -